Liquidia (LQDA) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

LQDA Stock Forecast


Liquidia stock forecast is as follows: an average price target of $22.33 (represents a 100.99% upside from LQDA’s last price of $11.11) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

LQDA Price Target


The average price target for Liquidia (LQDA) is $22.33 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $17.00. This represents a potential 100.99% upside from LQDA's last price of $11.11.

LQDA Analyst Ratings


Buy

According to 6 Wall Street analysts, Liquidia's rating consensus is 'Buy'. The analyst rating breakdown for LQDA stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Liquidia Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 20, 2024Jason GerberryBank of America Securities$23.00$9.79134.93%107.02%
Aug 19, 2024Kambiz YazdiJefferies$17.00$9.5977.27%53.02%
Aug 19, 2024Strong BuyRaymond James$27.00$9.82174.95%143.02%
May 14, 2024Kambiz YazdiJefferies$23.00$11.9692.31%107.02%
Sep 02, 2022Needham$16.00$4.86229.22%44.01%
Sep 01, 2022Liana MoussatosWedbush$3.00$5.77-48.01%-73.00%
Jul 20, 2022BTIG$17.00$5.42213.65%53.02%

The latest Liquidia stock forecast, released on Aug 20, 2024 by Jason Gerberry from Bank of America Securities, set a price target of $23.00, which represents a 134.93% increase from the stock price at the time of the forecast ($9.79), and a 107.02% increase from LQDA last price ($11.11).

Liquidia Price Target by Period


1M3M12M
# Anlaysts--4
Avg Price Target--$22.50
Last Closing Price$11.11$11.11$11.11
Upside/Downside-100.00%-100.00%102.52%

In the current month, the average price target of Liquidia stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Liquidia's last price of $11.11. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 03, 2024Raymond JamesBuyBuyHold
Aug 20, 2024BTIGBuyBuyHold
Aug 20, 2024H.C. WainwrightBuyBuyHold
Aug 19, 2024JefferiesBuyBuyHold
Aug 19, 2024Raymond JamesOutperformStrong BuyUpgrade
Aug 16, 2024Raymond JamesOutperformInitialise
Aug 08, 2024NeedhamBuyBuyHold
Jul 18, 2024NeedhamBuyBuyHold
Jun 25, 2024NeedhamBuyBuyHold
Jun 24, 2024OppenheimerPerformInitialise
May 15, 2024NeedhamBuyBuyHold
May 14, 2024JefferiesBuyBuyHold
Apr 01, 2024NeedhamBuyBuyHold
Mar 13, 2024WedbushBuyBuyHold
Mar 13, 2024NeedhamUnderperformUnderperformHold
Jan 05, 2024NeedhamUnderperformUnderperformHold
Jan 05, 2024WedbushBuyBuyHold
Mar 17, 2023NeedhamBuyBuyHold
Sep 01, 2022NeedhamBuyBuyHold
Jul 20, 2022BTIGBuyBuyHold

Liquidia's last stock rating was published by Raymond James on Oct 03, 2024. The company gave LQDA a "Buy" rating, the same as its previous rate.

Liquidia Financial Forecast


Liquidia Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Sep 19Jun 19Mar 19Sep 18
Revenue--------$4.53M$3.68M$4.79M$4.49M$5.36M$3.17M$3.92M$3.49M$-3.34M$3.18M$3.38M$3.08M-$8.07M-$169.73K
Avg Forecast$28.54M$15.98M$6.48M$4.17M$4.54M$4.16M$9.45M$4.47M$4.73M$4.33M$4.32M$3.95M$3.55M$3.76M$3.59M$3.30M$3.05M$2.73M$2.04M$951.25K$644.50K$683.00K$925.50K$116.56K
High Forecast$35.21M$19.72M$7.99M$5.14M$6.06M$5.13M$9.45M$4.47M$5.61M$4.33M$5.32M$4.87M$4.38M$3.76M$3.59M$3.30M$3.05M$2.73M$2.04M$951.25K$644.50K$683.00K$925.50K$139.87K
Low Forecast$23.29M$13.04M$5.29M$3.40M$3.39M$3.39M$9.45M$4.47M$3.76M$4.33M$3.52M$3.22M$2.90M$3.76M$3.59M$3.30M$3.05M$2.73M$2.04M$951.25K$644.50K$683.00K$925.50K$93.25K
# Analysts1112634454443333444713131315
Surprise %--------0.96%0.85%1.11%1.14%1.51%0.84%1.09%1.06%-1.10%1.16%1.65%3.24%-11.82%-1.46%

Liquidia's average Quarter revenue forecast for Mar 24 based on 4 analysts is $4.47M, with a low forecast of $4.47M, and a high forecast of $4.47M. LQDA's average Quarter revenue forecast represents a -1.25% decrease compared to the company's last Quarter revenue of $4.53M (Dec 23).

Liquidia EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Sep 19Jun 19Mar 19Sep 18
# Analysts1112634454443333444713131315
EBITDA--------$-25.86M$-14.89M$-22.82M$-8.31M$-5.83M$-7.34M$-7.90M$-13.52M$-11.36M$-5.53M$-4.76M$-7.37M$-12.34M$-5.03M$-12.94M$-8.63M
Avg Forecast$-28.54M$-15.98M$-6.48M$-4.17M$-4.54M$-4.16M$-9.45M$-6.98M$-4.73M$-4.33M$-4.32M$-7.47M$-9.43M$-3.76M$-3.59M$-7.98M$-3.05M$-2.73M$-2.04M$-7.37M$-644.50K$-683.00K$-8.58M$-5.16M
High Forecast$-23.29M$-13.04M$-5.29M$-3.40M$-3.39M$-3.39M$-9.45M$-5.58M$-3.76M$-4.33M$-3.52M$-5.97M$-7.54M$-3.76M$-3.59M$-6.39M$-3.05M$-2.73M$-2.04M$-5.90M$-644.50K$-683.00K$-6.87M$-4.13M
Low Forecast$-35.21M$-19.72M$-7.99M$-5.14M$-6.06M$-5.13M$-9.45M$-8.38M$-5.61M$-4.33M$-5.32M$-8.96M$-11.31M$-3.76M$-3.59M$-9.58M$-3.05M$-2.73M$-2.04M$-8.85M$-644.50K$-683.00K$-10.30M$-6.19M
Surprise %--------5.46%3.44%5.29%1.11%0.62%1.95%2.20%1.69%3.73%2.02%2.33%1.00%19.14%7.36%1.51%1.67%

undefined analysts predict LQDA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Liquidia's previous annual EBITDA (undefined) of $NaN.

Liquidia Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Sep 19Jun 19Mar 19Sep 18
# Analysts1112634454443333444713131315
Net Income--------$-27.45M--$-13.13M$-5.97M$-9.35M$-9.92M$-16.94M-$-7.28M$-6.55M$-9.18M$-13.42M$-5.90M$-13.77M$-9.67M
Avg Forecast$-31.99M$-38.94M$-31.58M$-28.81M$-29.93M$-29.27M$-26.75M$-7.67M$-18.54M$-16.85M$-12.72M$-8.20M$-10.09M$-13.41M$-18.15M$-8.77M$-9.36M$-9.17M$-12.04M$-9.18M$-45.61M$-48.92M$-9.04M$-5.79M
High Forecast$-24.35M$-29.64M$-24.04M$-21.93M$-19.95M$-22.28M$-20.36M$-6.13M$-17.73M$-12.82M$-9.68M$-6.56M$-8.07M$-13.41M$-18.15M$-7.01M$-9.36M$-9.17M$-12.04M$-7.35M$-45.61M$-48.92M$-7.23M$-4.63M
Low Forecast$-41.71M$-50.78M$-41.18M$-37.57M$-37.60M$-38.16M$-34.87M$-9.20M$-19.34M$-21.96M$-16.59M$-9.84M$-12.11M$-13.41M$-18.15M$-10.52M$-9.36M$-9.17M$-12.04M$-11.02M$-45.61M$-48.92M$-10.84M$-6.94M
Surprise %--------1.48%--1.60%0.59%0.70%0.55%1.93%-0.79%0.54%1.00%0.29%0.12%1.52%1.67%

Liquidia's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. LQDA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Liquidia SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Sep 19Jun 19Mar 19Sep 18
# Analysts1112634454443333444713131315
SG&A--------$17.14M$10.56M$9.24M$7.79M$6.19M$6.74M$6.94M$12.54M$8.47M$4.88M$4.42M$5.34M$2.38M$2.41M$3.02M$2.28M
Avg Forecast$257.29M$144.08M$58.41M$37.57M$40.95M$37.48M$85.19M$40.34M$42.66M$39.07M$38.90M$35.59M$2.43M$33.90M$32.35M$29.71M$27.46M$24.65M$18.43M$8.58M$5.81M$6.16M$8.34M$1.05M
High Forecast$317.44M$177.76M$72.06M$46.35M$54.61M$46.24M$85.19M$40.34M$50.56M$39.07M$48.00M$43.91M$2.91M$33.90M$32.35M$29.71M$27.46M$24.65M$18.43M$8.58M$5.81M$6.16M$8.34M$1.26M
Low Forecast$210.02M$117.61M$47.68M$30.66M$30.58M$30.60M$85.19M$40.34M$33.87M$39.07M$31.76M$29.05M$1.94M$33.90M$32.35M$29.71M$27.46M$24.65M$18.43M$8.58M$5.81M$6.16M$8.34M$840.69K
Surprise %--------0.40%0.27%0.24%0.22%2.55%0.20%0.21%0.42%0.31%0.20%0.24%0.62%0.41%0.39%0.36%2.17%

Liquidia's average Quarter SG&A projection for Mar 24 is $40.34M, based on 4 Wall Street analysts, with a range of $40.34M to $40.34M. The forecast indicates a 135.29% rise compared to LQDA last annual SG&A of $17.14M (Dec 23).

Liquidia EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Sep 19Jun 19Mar 19Sep 18
# Analysts1112634454443333444713131315
EPS--------$-0.42--$-0.20$-0.10$-0.15$-0.16$-0.32-$-0.14$-0.13$-0.21$-0.72$-0.31$-0.86$-0.83
Avg Forecast$-0.41$-0.50$-0.40$-0.37$-0.38$-0.37$-0.34$-0.32$-0.24$-0.22$-0.16$-0.16$-0.16$-0.18$-0.24$-0.21$-0.12$-0.12$-0.16$-0.21$-0.60$-0.64$-0.63$-0.34
High Forecast$-0.31$-0.38$-0.31$-0.28$-0.25$-0.28$-0.26$-0.25$-0.23$-0.16$-0.12$-0.12$-0.12$-0.18$-0.24$-0.21$-0.12$-0.12$-0.16$-0.21$-0.60$-0.64$-0.63$-0.27
Low Forecast$-0.53$-0.65$-0.53$-0.48$-0.48$-0.49$-0.45$-0.42$-0.25$-0.28$-0.21$-0.21$-0.20$-0.18$-0.24$-0.21$-0.12$-0.12$-0.16$-0.21$-0.60$-0.64$-0.63$-0.41
Surprise %--------1.77%--1.23%0.63%0.86%0.67%1.54%-1.17%0.83%0.99%1.21%0.48%1.36%2.44%

According to undefined Wall Street analysts, Liquidia's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to LQDA previous annual EPS of $NaN (undefined).

Liquidia Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
INZYInozyme Pharma$2.94$16.00444.22%Buy
XFORX4 Pharmaceuticals$0.74$3.67395.95%Buy
GOSSGossamer Bio$0.87$3.75331.03%Buy
LRMRLarimar Therapeutics$4.32$17.00293.52%Buy
ABOSAcumen Pharmaceuticals$1.96$7.00257.14%Buy
LYRALyra Therapeutics$0.18$0.50177.78%Hold
TERNTerns Pharmaceuticals$6.80$18.67174.56%Buy
KALVKalVista Pharmaceuticals$8.65$22.67162.08%Buy
LEGNLegend Biotech$34.68$89.60158.36%Buy
AGENAgenus$2.96$7.33147.64%Hold
IMCRImmunocore$29.40$70.20138.78%Buy
LQDALiquidia$11.31$22.3397.44%Buy
AMLXAmylyx Pharmaceuticals$4.28$8.2592.76%Buy
GERNGeron$3.93$6.8373.79%Buy
PCVXVaxcyte$89.86$148.8065.59%Buy
REPLReplimune Group$11.72$19.0062.12%Buy
BMRNBioMarin Pharmaceutical$67.19$94.4340.54%Buy
MIRMMirum Pharmaceuticals$42.65$57.0033.65%Buy
NRXPNRx Pharmaceuticals$1.64$2.0021.95%Buy
UTHRUnited Therapeutics$379.69$440.4015.99%Buy
TECHBio-Techne$75.27$82.339.38%Buy
KRONKronos Bio$0.96$1.004.17%Buy

LQDA Forecast FAQ


Is Liquidia a good buy?

Yes, according to 6 Wall Street analysts, Liquidia (LQDA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of LQDA's total ratings.

What is LQDA's price target?

Liquidia (LQDA) average price target is $22.33 with a range of $17 to $27, implying a 100.99% from its last price of $11.11. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Liquidia stock go up soon?

According to Wall Street analysts' prediction for LQDA stock, the company can go up by 100.99% (from the last price of $11.11 to the average price target of $22.33), up by 143.02% based on the highest stock price target, and up by 53.02% based on the lowest stock price target.

Can Liquidia stock reach $20?

LQDA's average twelve months analyst stock price target of $22.33 supports the claim that Liquidia can reach $20 in the near future.

What are Liquidia's analysts' financial forecasts?

Liquidia's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $22.62M (high $25.11M, low $20.71M), average EBITDA is $-25.13M (high $-21.818M, low $-29.012M), average net income is $-93.604M (high $-68.717M, low $-120M), average SG&A $203.96M (high $226.38M, low $186.7M), and average EPS is $-1.421 (high $-1.045, low $-1.835). LQDA's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $55.16M (high $68.06M, low $45.03M), average EBITDA is $-55.164M (high $-45.029M, low $-68.06M), average net income is $-131M (high $-99.958M, low $-171M), average SG&A $497.33M (high $613.61M, low $405.96M), and average EPS is $-1.677 (high $-1.276, low $-2.186).

Did the LQDA's actual financial results beat the analysts' financial forecasts?

Based on Liquidia's last annual report (Dec 2023), the company's revenue was $17.49M, beating the average analysts forecast of $17.33M by 0.92%. Apple's EBITDA was $-73.384M, beating the average prediction of $-20.846M by 252.03%. The company's net income was $0, missing the average estimation of $-56.302M by -100.00%. Apple's SG&A was $44.74M, missing the average forecast of $156.22M by -71.36%. Lastly, the company's EPS was $0, missing the average prediction of $-0.777 by -100.00%. In terms of the last quarterly report (Dec 2023), Liquidia's revenue was $4.53M, missing the average analysts' forecast of $4.73M by -4.24%. The company's EBITDA was $-25.858M, beating the average prediction of $-4.732M by 446.50%. Liquidia's net income was $-27.45M, beating the average estimation of $-18.538M by 48.08%. The company's SG&A was $17.14M, missing the average forecast of $42.66M by -59.81%. Lastly, the company's EPS was $-0.42, beating the average prediction of $-0.237 by 77.44%